Inductive Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $25.1M

  • Investors
  • 16

Inductive Bio General Information

Description

Developer of a machine learning platform designed to accelerate the compound optimization process. The company's platform specializes in building datasets and machine learning (ML) models to map the drivers of small molecule absorption, distribution, metabolism, excretion, and toxicity (ADMET), enabling scientists to optimize initial compounds into leads and development candidates faster and with a better balance of properties which helps them develop new therapeutics.

Contact Information

Formerly Known As
Prospect Heights Research
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 550 Vanderbilt Avenue
  • Suite 730, Brooklyn
  • New York, NY 11238
  • United States
+1 (646)
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Corporate Office
  • 550 Vanderbilt Avenue
  • Suite 730, Brooklyn
  • New York, NY 11238
  • United States
+1 (646)

Inductive Bio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inductive Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 07-May-2025 $25.1M Completed Generating Revenue
1. Seed Round 13-Dec-2023 Completed Startup
To view Inductive Bio’s complete valuation and funding history, request access »

Inductive Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Seed 1,451,705 $0.000100 6% $2.94 $2.94 1x $2.94 15.77%
To view Inductive Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Inductive Bio Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ensemble Labs Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
Obvious Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Inductive Bio FAQs

  • When was Inductive Bio founded?

    Inductive Bio was founded in 2021.

  • Where is Inductive Bio headquartered?

    Inductive Bio is headquartered in New York, NY.

  • What industry is Inductive Bio in?

    Inductive Bio’s primary industry is Decision/Risk Analysis.

  • Is Inductive Bio a private or public company?

    Inductive Bio is a Private company.

  • What is the current valuation of Inductive Bio?

    The current valuation of Inductive Bio is .

  • What is Inductive Bio’s current revenue?

    The current revenue for Inductive Bio is .

  • How much funding has Inductive Bio raised over time?

    Inductive Bio has raised $29.4M.

  • Who are Inductive Bio’s investors?

    Ensemble Labs, , , , and Obvious Ventures are 5 of 16 investors who have invested in Inductive Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process